MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s42000-021-00281-7

Медицинская библиотека · Hormones (Athens, Greece) · 2021

Early postoperative prediction of both disease remission and long-term disease control in acromegaly using the oral glucose tolerance test.

Sakata Kiyohiko, Nagata Yui, Takeshige Nobuyuki, Kikuchi Jin, Shikata Masato, Ashida Kenji, Nomura Masatoshi, Morioka Motohiro

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Transsphenoidal surgery (TSS) is the cornerstone of acromegaly treatment. Two biochemical parameters, growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels, sometimes diverge postoperatively; however, it is important to maintain disease control without further treatment, regardless of whether these parameters converge. This study investigated whether remission and long-term disease control could be predicted using early postoperative GH and IGF-1 levels.

METHODS

We reviewed 36 consecutive surgically treated patients with acromegaly. IGF-1 levels and minimum GH levels during an oral glucose tolerance test (OGTT) were evaluated at 2 weeks, as well as at 3 months postoperatively. After comparison between the remission and nonremission groups, we analyzed whether early postoperative parameters could predict remission and long-term disease control.

RESULTS

Twenty-five patients (69.4%, Group A) achieved remission within 1 year postoperatively. Of the remaining patients (median follow-up period, 53 months), seven (19.5%, Group B) maintained normal IGF-1 levels without treatment, whereas four (11.1%, Group C) required additional treatment. GH levels <1.5 ng/mL measured on the morning after surgery and nadir GH levels <0.7 ng/mL during the OGTT conducted at 2 weeks postoperatively were predictive of remission, with the latter demonstrating 95.2% sensitivity and 100% specificity. All group C patients had nadir GH levels ≥0.7 ng/mL during the OGTT and IGF-1 levels ≥SD +3 at 2 weeks postoperatively.

CONCLUSION

Early postoperative nadir GH levels during the OGTT and IGF-1 levels at 2 weeks postoperatively demonstrated excellent predictive value for both endocrinological remission and the necessity for additional treatment.

Для цитирования: Sakata Kiyohiko, Nagata Yui, Takeshige Nobuyuki, Kikuchi Jin, Shikata Masato, Ashida Kenji, Nomura Masatoshi, Morioka Motohiro. Early postoperative prediction of both disease remission and long-term disease control in acromegaly using the oral glucose tolerance test.. Hormones (Athens, Greece). 2021. DOI: 10.1007/s42000-021-00281-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.